Chinese Market Report for Bone Graft Substitutes 2016 – MedCore

Chinese Market Report for Bone Graft Substitutes 2016 – MedCore

0

Bone is a biologically active tissue and will regenerate whenever possible; however, there are instances where the damage is significant enough to warrant a scaffold to help rejoin the fissure or cavity. Bone grafting is a surgical procedure in which damaged bone is replaced with autograft tissue, allograft tissue or a bone graft substitute, which can be either synthetic or metal.

  • Year: 2016
  • Scope: 2012-2022
  • Region: China
  • Published Date: 02/01/2016
  • Pages: 61
  • Type: MedCore

During an autograft procedure, tissue is harvested from the patient’s iliac crest, or possibly the distal femur or proximal tibia, and placed at the injury site. An allograft procedure uses donated cadaveric tissue. A grafting procedure using a bone graft substitute replaces human tissue with a synthetic or metal material. For the purposes of this report, metal replacement materials and bone cement will be excluded, as they are not considered biomaterials.
Material transplanted (or implanted) during a grafting procedure provides a scaffold where the body can generate new bone tissue through osteogenesis, thereby repairing the skeletal system. The three elements involved in osteogenesis are osteoconduction, osteogenicity and osteoinduction. Osteoconduction refers to the scaffolding that is needed to support new bone growth. Osteogenicity is the property of being able to form new bone tissue. Osteoinduction is the stimulation of the body to produce new bone tissue, usually by means of growth factors such as bone morphogenetic proteins (BMPs). Bone grafting is largely performed in dental procedures to replace missing teeth; within orthopedics, spinal fusion is the main driver of bone graft and bone graft substitute use. Indirect competition for the bone graft substitute market mainly comes from BMPs. The motion preservation device market, which aims to stabilize the spine without vertebral fusion, also competes with the bone graft substitute market.



The "Chinese Market Report Suite for Orthopedic Biomaterials 2016 - MedSuite" includes analysis on the following companies currently active in this market:
Allgens Medical
Biocomposites
Biolu Biomaterials
Bloomage Freda Biopharm
Datsing Biotech
DePuy Synthes
FocusChem
Genzyme
Guona Keji
Hanghzhou Gallop
Harbin Gloria Pharmaceutical
Jinxingda Company (Tianjin)
Kaisha
Kunming Baker Norton
Kunming Baker Norton
Medtronic
Meiji Seika
Novabone
Osteolink Biomaterials
Rebone Biomaterials
Seikagaku
Shanghai Anjiu Biotechnology
Shanghai HaoHai
Shanghai Jingfeng Pharmaceutical
Shanxi OsteoRad Biomaterial
Wright Medical
Xin Kang Chen
Yunkanghengye

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link